Active surveillance protocol in prostate cancer in Portugal

被引:1
|
作者
Gaspar, S. R. da Silva [1 ]
Fernandes, M. [1 ]
Castro, A. [1 ]
Oliveira, T. [1 ]
Dias, J. Santos [1 ]
dos Reis, J. Palma [1 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Urol, Lisbon, Portugal
来源
ACTAS UROLOGICAS ESPANOLAS | 2022年 / 46卷 / 06期
关键词
Active surveillance; Prostate cancer; Watchful waiting; Portugal; MRI; Biopsy; VERSION; 2; MEN; COMPLICATIONS; MANAGEMENT; BIOPSIES;
D O I
10.1016/j.acuro.2021.01.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine clinical practice patterns in locally managing patients under an active surveillance protocol among Portuguese urologists. Introduction: Prostate cancer (PCa) is a heterogeneous disease with many prostate adeno-carcinomas being indolent and a low probability of ever causing symptoms or death. Active surveillance (AS) is a form of conservative management aimed to reduce over-treatment for low-risk PCa patients. Over the years, experience with AS has grown considerably and is now standard in some countries, however a universal protocol still does not exist. Methods: Nationwide anonymous e-survey concerning habits and practices on AS among Portu-guese urologists, that consisted of 12 questions and was sent electronically to all 368 current members of the Portuguese Urological Association. Results: 56 urologists were surveyed (15.21% answer rate), evenly distributed geographically and allocated according to years of experience as well as number of PCa patients managed monthly. The vast majority of respondents recommends AS to their patients, particularly ISUP grade 1 patients, whose PSA serum level is bellow 20ng/mL. Observance of AS programs by patients was not in question but concerns exist over psychological morbidity while harboring disease. Majority believed that international guidelines surveillance protocols were adequate and sufficient, but there are some constraints concerning availability of periodic MRIs and re -biopsy needs. Conclusions: AS seems to be sustained in urologist clinical practice, although patients still lag to adhere and choose for active treatment. AS may not be an easy choice for patients and clinicians due to uncertainty of disease progression, risk of loss to follow-up and repeated biopsies but is also a cause for anxiety, depression, uncertainty and a perception of danger. (c) 2021 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:329 / 339
页数:11
相关论文
共 50 条
  • [1] Prostate Cancer and the Increasing Role of Active Surveillance
    Alonzo, David Gabriel
    Mure, Amanda Lynne
    Soloway, Mark S.
    POSTGRADUATE MEDICINE, 2013, 125 (05) : 109 - 116
  • [2] Multiparametric magnetic resonance imaging in the active surveillance of prostate cancer: protocol, risk stratification, and surveillance
    Qin, Xiaoyan
    Lv, Jian
    Zhu, Xiqi
    JOURNAL OF MENS HEALTH, 2024, 20 (04) : 12 - 18
  • [3] Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan
    Mitsuzuka, Koji
    Koga, Hirofumi
    Sugimoto, Mikio
    Arai, Yoichi
    Ohyama, Chikara
    Kakehi, Yoshiyuki
    Naito, Seiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (08) : 754 - 759
  • [4] Active surveillance of prostate cancer
    Ploussard, G.
    Hennequin, C.
    Rozet, F.
    CANCER RADIOTHERAPIE, 2017, 21 (6-7): : 437 - 441
  • [5] Active surveillance for prostate cancer
    Shill, Daniela K.
    Roobol, Monique J.
    Ehdaie, Behfar
    Vickers, Andrew J.
    Carlsson, Sigrid, V
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (06) : 2809 - 2819
  • [6] Active surveillance in prostate cancer: a concept analysis
    Horrill, Tara
    JOURNAL OF CLINICAL NURSING, 2016, 25 (7-8) : 1166 - 1172
  • [7] Active surveillance or prostate cancer
    Mottet, N.
    ONCOLOGIE, 2012, 14 (02) : 74 - 78
  • [8] Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review
    Schoots, Ivo G.
    Petrides, Neophytos
    Giganti, Francesco
    Bokhorst, Leonard P.
    Rannikko, Antti
    Klotz, Laurence
    Villers, Arnauld
    Hugosson, Jonas
    Moore, Caroline M.
    EUROPEAN UROLOGY, 2015, 67 (04) : 627 - 636
  • [9] Use of multiparametric magnetic resonance imaging in prostate cancer active surveillance
    Glass, Allison S.
    Dall'Era, Marc A.
    BJU INTERNATIONAL, 2019, 124 (05) : 730 - 737
  • [10] Active surveillance in prostate cancer: the French protocol
    Mottet, Nicolas
    Irani, Jacques
    PROGRES EN UROLOGIE, 2008, 18 (04): : F12 - F16